3 | SEC Filings Hub

Filing metadata

Accession number: 0001415889-24-023834
Form type: Form 3
Filer: Aurinia Pharmaceuticals Inc.
CIK: CIK 1600620
Filed: Sep 23, 2024
Reporting period: Sep 12, 2024
Description: Initial ownership

Documents

0001415889-24-023834-index.htm

Complete submission

0001415889-24-023834.txt

directory listing

Filed by

Aurinia Pharmaceuticals Inc.